Imago-in' places

Imago reunites FerroKin vets to target gene expression in blood disorders

The team at Imago BioSciences Inc. raised a $26.5 million series A round geared to helping them repeat their performance at hematology play FerroKin BioSciences Inc., this time with compounds that modulate gene expression to treat rare genetic

Read the full 381 word article

How to gain access

Continue reading with a
two-week free trial.